Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Feb 26;1(5799):527-30.
doi: 10.1136/bmj.1.5799.527.

Cell-mediated immune responses in chronic liver diseases

Cell-mediated immune responses in chronic liver diseases

M G Smith et al. Br Med J. .

Abstract

Studies of the cell-mediated response to liver antigens, using the leucocyte migration test, in 163 patients with various liver disorders showed that abnormal responses were almost confined to active chronic hepatitis (53% abnormal), primary biliary cirrhosis (64%), and cryptogenic cirrhosis (29%). The test was also abnormal in five out of seven patients with jaundice due to drug hypersensitivity and in one patient with acute infectious hepatitis at a time when mitochondrial antibodies were present in the serum. More of those with active chronic hepatitis on prednisone or azathioprine had normal tests than of those who were untreated, and in 8 out of 10 examined serially during therapy there was an accompanying improvement in leucocyte migration. Abnormal responses to salivary gland or kidney antigens were also found in nearly half of those with features of Sjögren's syndrome or renal tubular acidosis as part of a multisystem involvement-this, though occurring in cryptogenic cirrhosis, was found with greater frequency in active chronic hepatitis and primary biliary cirrhosis. These cell-mediated immune responses, perhaps triggered by the initial damage to the liver from viral or other agents, may be responsible both for the perpetuation of the liver disease and, because of common surface antigens, for the damage to other organs.

PubMed Disclaimer

References

    1. Clin Exp Immunol. 1966 Jul;1(3):237-62 - PubMed
    1. Acta Med Scand. 1967 Feb;181(2):247-56 - PubMed
    1. J Clin Pathol. 1970 Mar;23(2):95-8 - PubMed
    1. Proc R Soc Med. 1970 May;63(5):527-31 - PubMed
    1. Br Med J. 1970 Nov 7;4(5731):340-2 - PubMed

MeSH terms

LinkOut - more resources